MERCK: INTISMERAN PLUS KEYTRUDA SIGNIFICANTLY REDUCED RISK OF DISTANT METASTASIS OR DEATH BY 38% VS KEYTRUDA ALONE 22-OCT-2026 02:29 PM ET